EAM
LXRX icon

Eagle Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Eagle Asset Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,832,549
Closed -$34.5M – 642
2017
Q3 		$34.5M Sell
2,832,549
-28,516
-1% -$421K 0.2% 174
2017
Q2 		$47.1M Buy
2,861,065
+8,756
+0.3% +$136K 0.28% 128
2017
Q1 		$40.9M Sell
2,852,309
-14,307
-0.5% -$212K 0.26% 126
2016
Q4 		$39.6M Buy
2,866,616
+1,138,662
+66% +$18.3M 0.26% 123
2016
Q3 		$31.2M Buy
1,727,954
+49,222
+3% +$792K 0.21% 148
2016
Q2 		$24.1M Buy
1,678,732
+196,759
+13% +$2.67M 0.17% 181
2016
Q1 		$17.7M Buy
1,481,973
+867,419
+141% +$9.09M 0.12% 237
2015
Q4 		$8.43M Buy
+614,554
New +$7.56M 0.06% 355

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return